JFL Life Sciences Limited engages in the manufacture and sale of pharmaceutical products in India and internationally. It offers B-Lactam dry powder injections, beta lactam tablet and capsule in solid oral dosage form, oral rehydration solutions, and general tablets and capsules. The company also exports its products to Africa, the Middle East, and CIS countries through merchant exporters. JFL Life Sciences Limited was incorporated in 2010 and is based in Ahmedabad, India.
Metrics to compare | JFLL | Peers Peers - average of corresponding metrics from companies closely matching JFLL: MOREPENLAB, KOPRAN, 540694, ACCENTMIC, 524790 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJFLLPeersSector |
---|---|---|---|---|
P/E Ratio | 10.3x | 26.1x | −0.6x | |
PEG Ratio | 0.41 | 0.23 | 0.00 | |
Price/Book | 1.1x | 3.1x | 2.6x | |
Price / LTM Sales | 0.5x | 2.3x | 3.3x | |
Upside (Analyst Target) | - | 13.6% | 40.1% | |
Fair Value Upside | Unlock | 6.4% | 5.3% | Unlock |